Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
نویسندگان
چکیده
منابع مشابه
Blood-Based Proteomic Biomarkers of Alzheimer’s Disease Pathology
The complexity of Alzheimer's disease (AD) and its long prodromal phase poses challenges for early diagnosis and yet allows for the possibility of the development of disease modifying treatments for secondary prevention. It is, therefore, of importance to develop biomarkers, in particular, in the preclinical or early phases that reflect the pathological characteristics of the disease and, moreo...
متن کاملProteomic biomarkers for autoimmune disease.
Autoimmune diseases affect 3% of the world population, yet the diagnosis and classification of autoimmune diseases remain based on clinical examination combined with traditional laboratory tests and imaging studies. The development of genomic and proteomic technologies provides an unprecedented ability to identify novel biosignatures to diagnose, classify, and guide therapeutic decision making ...
متن کاملProteomic Biomarkers in Alzheimer s disease
Alzheimer’s disease (AD) is a major problem of health in developed countries. From a pathogenic perspective, this prevalent form of dementia is a polygenic/complex disorder in which over 600 defective genes distributed across the human genome may be involved, in conjunction with epigenetic aberrations and diverse environmental risk factors [1]. The abnormal expression of genes and subsequent po...
متن کاملUrinary proteomic biomarkers in coronary artery disease.
Urinary proteomics is emerging as a powerful non-invasive tool for diagnosis and monitoring of variety of human diseases. We tested whether signatures of urinary polypeptides can contribute to the existing biomarkers for coronary artery disease (CAD). We examined a total of 359 urine samples from 88 patients with severe CAD and 282 controls. Spot urine was analyzed using capillary electrophores...
متن کاملAmelioration of Symptoms and Biomarkers of Alzheimers Disease by Physical Exercise
Physical exercise advantages have been manifested in several neurodegenerative and/or neuropsychiatric disorders implying that these, largely non-invasive, non-pharmacologic interventions, ought to be examined closely in the Alzheimer’s disease (AD) and other dementias context. Thus, according to the tenets of an increasingly broad consensus, preventative and interventional agents for AD and de...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Frontiers in Neurology
سال: 2015
ISSN: 1664-2295
DOI: 10.3389/fneur.2015.00236